PureTech Health PLC
NASDAQ:PRTC

Watchlist Manager
PureTech Health PLC Logo
PureTech Health PLC
NASDAQ:PRTC
Watchlist
Price: 16.64 USD Market Closed
Market Cap: 398.2m USD

Relative Value

The Relative Value of one PRTC stock under the Base Case scenario is hidden USD. Compared to the current market price of 16.64 USD, PureTech Health PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PRTC Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
50
vs Industry
4
Median 3Y
68.9
Median 5Y
64.1
Industry
8
vs History
15
vs Industry
Median 3Y
-6.7
Median 5Y
-10.7
Industry
23.5
Forward
-0.3
vs History
vs Industry
Median 3Y
-4.2
Median 5Y
-4.5
Industry
21.9
vs History
vs Industry
Median 3Y
-4.1
Median 5Y
-4.3
Industry
24.3
vs History
80
vs Industry
54
Median 3Y
1.4
Median 5Y
1.5
Industry
3.2
vs History
vs Industry
Median 3Y
-4 874.7
Median 5Y
-4 867.8
Industry
8.1
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.1
vs History
28
vs Industry
0
Median 3Y
269.4
Median 5Y
269.4
Industry
5.9
Forward
2.2
vs History
19
vs Industry
0
Median 3Y
262.3
Median 5Y
262.3
Industry
6.2
Forward
2.1
vs History
9
vs Industry
0
Median 3Y
282
Median 5Y
258.6
Industry
7.7
vs History
9
vs Industry
0
Median 3Y
281.4
Median 5Y
249.6
Industry
6.3
vs History
vs Industry
Median 3Y
-144.2
Median 5Y
-94.5
Industry
5.6

Multiples Across Competitors

PRTC Competitors Multiples
PureTech Health PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
PureTech Health PLC
NASDAQ:PRTC
301.3m USD 63.5 8 272.8 264.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 837 682.7 -160 825.5 -195 293.4 -193 064.9
US
Abbvie Inc
NYSE:ABBV
389.1B USD 6.5 165.7 16.1 22.8
US
Amgen Inc
NASDAQ:AMGN
172B USD 4.8 24.6 17.8 17.8
US
Gilead Sciences Inc
NASDAQ:GILD
145.7B USD 5 18 12 12
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.1B USD 9.6 30.8 22.5 23.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 082 -531.3 -578.5 -563.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.9B USD 5.6 17.4 16.6 18.8
AU
CSL Ltd
ASX:CSL
83.5B AUD 3.6 18.6 12.6 15.7
NL
argenx SE
XBRU:ARGX
44.1B EUR 14.3 33.7 58.1 59.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
51.4B USD 16 1 180.3 159.1 193
P/E Multiple
Earnings Growth PEG
US
PureTech Health PLC
NASDAQ:PRTC
Average P/E: 166.3
8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 825.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
165.7
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.6
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.8
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.4
10%
1.7
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
NL
argenx SE
XBRU:ARGX
33.7
40%
0.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 180.3
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
PureTech Health PLC
NASDAQ:PRTC
Average EV/EBITDA: 65.3
272.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 293.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.1
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
17.8
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12
7%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.5
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
11%
1.5
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
NL
argenx SE
XBRU:ARGX
58.1
810%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
159.1
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
PureTech Health PLC
NASDAQ:PRTC
Average EV/EBIT: 69.8
264.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 064.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.8
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.8
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
13%
1.4
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
NL
argenx SE
XBRU:ARGX
59.7
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
193
N/A N/A